Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 06:41 ET | Source: Yimutian Inc.

Yimutian Inc. Provides 2026 Strategic Update: Financing on Track, Management to Purchase No Less Than US$3 Million in Company Shares, Full-Year Revenue Expected to Reach RMB 1 Billion

BEIJING, March 24, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. (the "Company") today issued a strategic update to investors and market participants, outlining the Company's capital plan, equity...
March 24, 2026 06:30 ET | Source: Amaze Holdings, Inc

Amaze and LA Times Studios to Launch Food Channel LA, a Next-Generation Creator-led Commerce Platform

New Platform Marks LA Times Studios’ Move into Social Commerce Built Through Amaze’s Operating Studio Model, the Platform Will Combine the LA Times Studios Brand Power with Amaze’s End-to-End...
March 24, 2026 06:30 ET | Source: Bimergen Energy Corporation

Bimergen Energy to Present its $2B Growth Strategy at the Emerging Growth Virtual Conference on April 2nd

Newport Beach, CA, March 24, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a developer, owner, and operator of utility-scale and distributed battery energy...
March 24, 2026 06:00 ET | Source: Quotient Therapeutics, Inc.

Quotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology

CAMBRIDGE, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has entered a multi-year...
March 24, 2026 04:00 ET | Source: Global Licensing Group

Netflix’s Chief Marketing Officer, Marian Lee, Takes Center Stage at Licensing Expo 2026 for an Opening Keynote on the Netflix Effect and Fandom

Licensing Expo announces the keynote featuring Marian Lee, Chief Marketing Officer of Netflix, in a session moderated by License Global on fan engagement
March 24, 2026 03:27 ET | Source: GENENTA SCIENCE SPA

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

MILAN, March 24, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and...
March 24, 2026 03:12 ET | Source: Sidetrade

Mission Trail Capital Takes 5% Stake in Sidetrade, Second US Investor to Build Significant Position in Under Three Months

Sidetrade (Euronext Growth: ALBFR), the AI-native Order-to-Cash platform recognized as a Leader in the Gartner® Magic Quadrant™, announces that Mission Trail Capital Management LLC, a Texas-based...
March 24, 2026 02:30 ET | Source: Sanofi Winthrop Industrie

Press release: Availability of the Q1 2026 aide-mémoire

Availability of the Q1 2026 aide-mémoire Paris, France – March 24, 2026. Sanofi announced today the availability of its Q1 2026 aide-mémoire on the "Investors" page of the company's website: First...
March 24, 2026 02:00 ET | Source: Biotalys NV

Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting

Biotalys announces that it will publish its annual report and financial results for the full year of 2025 on Wednesday, 29 April 2026 at 07:00 CEST.
March 24, 2026 02:00 ET | Source: Pharming Group N.V.

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)Approval is based on positive Phase III data from multinational and Japanese studies in patients...